These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3120354)
1. Antitumor activity of cyclophosphamide and lipopolysaccharide in tumor-bearing mice pretreated with BCG. Sato H; Ito M; Abe T; Kumano N; Motomiya M; Konno K Tohoku J Exp Med; 1987 Oct; 153(2):151-60. PubMed ID: 3120354 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of lipopolysaccharide in tumor-bearing mice pretreated with BCG. Sato H; Ito M; Abe T; Kumano N; Motomiya M; Konno K Tohoku J Exp Med; 1986 Dec; 150(4):391-9. PubMed ID: 3105117 [TBL] [Abstract][Full Text] [Related]
3. Chemical analyses and antitumor activity of hydrosoluble substances from Mycobacterium bovis, strain BCG. Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K Tohoku J Exp Med; 1983 May; 140(1):35-43. PubMed ID: 6191409 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic analysis of high antitumor effect of intradermal administration of lipopolysaccharide from Pantoea Agglomerans. Iwamoto I; Goto S; Kera J; Soma G; Takeuchi S; Nagata Y Med Oncol; 1996 Jun; 13(2):103-9. PubMed ID: 9013473 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide. Abe S; Tsubouchi J; Takahashi K; Yamazaki M; Mizuno D Gan; 1982 Dec; 73(6):961-7. PubMed ID: 7160585 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions. Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid. Youn JK; Lacour F; Hue G Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of Klebsiella 03 lipopolysaccharide in mice. Miyamoto K; Koshiura R; Hasegawa T; Kato N Jpn J Pharmacol; 1984 Sep; 36(1):51-7. PubMed ID: 6503048 [TBL] [Abstract][Full Text] [Related]
9. [The synergistic action of lipopolysaccharide and muramyl dipeptide in the immunotherapy of DBA/2 mice with mastocytoma P815]. Rakhmilevich AL; Rakhimova MS Biull Eksp Biol Med; 1989 Dec; 108(12):721-4. PubMed ID: 2517487 [TBL] [Abstract][Full Text] [Related]
10. Elimination of tumor-enhancing cells by cyclophosphamide and its relevance to cyclophosphamide therapy of the murine mammary tumor. Nakajima H; Abe S; Masuko Y; Tsubouchi J; Yamazaki M; Mizuno D Gan; 1981 Oct; 72(5):723-31. PubMed ID: 7327373 [TBL] [Abstract][Full Text] [Related]
11. Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis. Ohnishi M; Kimura S; Yamazaki M; Oshima H; Mizuno DI; Abe S; Yamaguchi H Br J Cancer; 1994 Jun; 69(6):1038-42. PubMed ID: 8198967 [TBL] [Abstract][Full Text] [Related]
12. [Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice]. Moriya N Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1470-9. PubMed ID: 3908902 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system. Inagawa H; Nishizawa T; Noguchi K; Minamimura M; Takagi K; Goto S; Soma G; Mizuno D Anticancer Res; 1997; 17(3C):2153-8. PubMed ID: 9216680 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of bacterial lipopolysaccharide (LPS) alone and in combination with lentinan on MH-134 tumors in C3H/He mice. Moriya N; Miwa H; Orita K Acta Med Okayama; 1984 Feb; 38(1):49-55. PubMed ID: 6702486 [TBL] [Abstract][Full Text] [Related]
16. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice. Kawase I; Niitani H; Saijo N; Sasaki H; Morita T Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414 [TBL] [Abstract][Full Text] [Related]
17. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection. Qian JH; Kokudo S; Sato S; Hamaoka T; Fujiwara H Transplantation; 1987 Apr; 43(4):538-43. PubMed ID: 3495052 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070 [TBL] [Abstract][Full Text] [Related]
19. Inhibition and promotion of tumor growth by BCG: evidence for stimulation of humoral enhancing factors by BCG. Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K Int J Cancer; 1978 Jan; 21(1):67-71. PubMed ID: 624600 [TBL] [Abstract][Full Text] [Related]
20. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor]. Moriya N; Miwa H; Taketsuka S; Orita K Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]